ESTRO 36 Programme book and exhibition guide

Session 1: Tumour response 09:30-10:00 Genetic biomarkers: mutations G. Higgins (UK)

09:30-12:30

Coffee break

10:00-10:30

10:30-11:00 Genetic biomarkers: mRNA/miRNA profiles M. De Jong (NL) 11:00-11:30 Imaging biomarkers: PET/MR C. Gani (DE) 11:30:12:00 Imaging biomarkers: radiomics R. Leijenaar (NL) 12:00-12:30 Circulating tumour cells and cell-free DNA/RNA C. Decraene (FR)

Lunch

12:30-13:30

Session 2: Normal tissue 13:30-14:00 Genetic biomarkers, genomic DNA N. Andreassen (DK) 14:00-14:30 Genetic biomarkers, mitochondrial DNA P. Lambin (NL) 14:30-15:00 Functional biomarkers C. Talbot (UK)

13:30-15:00

Coffee break

15:00-15:30

Session 3: Validation 15:30-16:00 Design methodology for biomarker based radiotherapy trials S. Collette (BE) 16:00-16:30 Clinical trial example (EORTC-1219): randomised multicenter study testing a radiosensitiser and a predictive biomarker B. Sørensen (DK)

15:30-16:30

Final discussion M.C Vozenein (CH) and J.Alsner (DK)

16:30-17:00

Programme and Exhibition Guide | PROGRAMME

59